Sign in
4

Changes in Ownership

Starling Oncology, Inc. Filed Acc 0001628280-23-042815

Director acquired 50,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
O'Meara Maeve Director 2023-12-26 Grant or award +50,000 109,104 D
Loading xslF345X05/wk-form4_1703800674.xml…